Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Endometrial Neoplasms × Pafolacianine × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 2 Neoplasms 2 Gastrointestinal Neoplasms 2 Urinary Bladder Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Peritoneal Neoplasms 1 Pelvic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Appendiceal Neoplasms 1

Interventions

Paclitaxel 35 Carboplatin 28 pembrolizumab 22 Surveys and Questionnaires 20 Letrozole 14 Radiotherapy 13 Bevacizumab 13 Blood Specimen Collection 12 Metformin 11 Megestrol Acetate 11 olaparib 10 dostarlimab 10 Observation 9 Medroxyprogesterone Acetate 9 Indocyanine Green 9 Cisplatin 9 durvalumab 8 lenvatinib 7 Sentinel Lymph Node Biopsy 7 Radiation 7 Magnetic Resonance Spectroscopy 7 Lymph Node Excision 7 Early Intervention, Educational 7 atezolizumab 6 abemaciclib 6 Taxes 6 Specimen Handling 6 Methods 6 Hysterectomy 6 Everolimus 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07278986 2025-12-12

CYTALUX ISS

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡